Printer Friendly

Articles from Chain Drug Review (August 14, 1995)

1-19 out of 19 article(s)
Title Author Type Words
Aging population, lens wearers spur eye medication sales. 771
Aleve alters analgesics business. 681
Brands are making a comeback. 870
Chain drug stocks continue record-breaking streak. 858
Cough/cold segment hit by overcrowding. 1220
Creditors nix Phar-Mor bid to exit Chap. 11. 729
Fragrance market to see surge in new items. Sloan, Pat 817
Innovations driving growth in deodorants. 1907
It's time to reassess Proctor & Gamble. Pinto, David 857
Jergens restages bar soap line. 784
Laxative category still in doldrums. 767
NACDS moves ahead with EAS initiative. 815
NACDS steps up fight against Medicaid cuts. 330
O-T-C switches enhance role of pharmacists in health care. 635
P&G turns its attention to health care business. 896
Reformulations lift lice treatment sales. 850
Revco generates strong earnings gains during fiscal '95. 748
Role of private label is to reinforce a store's image. Biernbaum, David 1245
Switches revolutionizing antacids. 1469

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |